Old Web
English
Sign In
Acemap
>
authorDetail
>
Abhiroop Chakravarty
Abhiroop Chakravarty
Medicine
cost effectiveness
Internal medicine
Hypoglycemia
Metformin
4
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost-effectiveness of pembrolizumab in combination with axitinib as first-line treatment for advanced renal cell carcinoma.
2020
Journal of Clinical Oncology
Arielle G. Bensimon
Yichen Zhong
Umang Swami
Allison Briggs
Joshua Young
Yuan Feng
Yan Song
James Signorovitch
Oluwakayode Adejoro
Abhiroop Chakravarty
Mei Chen
Rodolfo F. Perini
Daniel M. Geynisman
Show All
Source
Cite
Save
Citations (1)
Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma.
2020
Current Medical Research and Opinion
Arielle G. Bensimon
Yichen Zhong
Umang Swami
Allison Briggs
Joshua Young
Yuan Feng
Yan Song
James Signorovitch
Oluwakayode Adejoro
Abhiroop Chakravarty
Mei Chen
Rodolfo F. Perini
Daniel M. Geynisman
Show All
Source
Cite
Save
Citations (3)
Comparison of costs and outcomes of dapagliflozin with other glucose-lowering therapy classes added to metformin using a short-term cost-effectiveness model in the US setting
2018
Journal of Medical Economics
Abhiroop Chakravarty
Mohini Rastogi
Praveen Dhankhar
Kelly F. Bell
Show All
Source
Cite
Save
Citations (15)
Abstract 039: Comparison of Costs & Outcomes of Dapagliflozin With Dipeptidyl Peptidase-4 Inhibitors Added to Metformin Using a Short-term Cost-effectiveness Model
2017
Circulation-cardiovascular Quality and Outcomes
Abhiroop Chakravarty
Mohini Rastogi
Praveen Dhankhar
Kelly F. Bell
Show All
Source
Cite
Save
Citations (0)
1